Universite de Caen Basse-Normandie;Organes Tissus Regeneration Reparation Remplacement - OTR3;Centre National de la Recherche Scientifique;Denis Barritault
The present invention relates to a pharmaceutical composition which includes a biocompatible polymer and a eukaryotic cell to be used as a drug for the prevention and/or treatment of tissue lesions of the central nervous system caused by cerebral vascular ischaemia. The present invention also relates to a pharmaceutical kit which includes a biocompatible polymer and a eukaryotic cell for the prevention and/or treatment of tissue lesions of the central nervous system caused by cerebral vascular ischaemia. The present invention can be used in particular in the human and veterinary pharmaceutical fields.
